Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer: A Prospective Phase II Trial (POHIM_EM Trial)
Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To investigate the non-inferiority of disease-free survival in women who received hypofractionated intensity-modulated whole pelvic radiation therapy (2.5 Gy x 16 fractions) after curative surgery for stage III endometrial cancer.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 20
Maximum Age: 80
Healthy Volunteers: f
View:
• histologically confirmed endometrioid type endometrial cancer
• completion of hysterectomy and surgical staging
• pathologically confirmed FIGO stage III
• ECOG performance status 0 or 1
• adjuvant chemotherapy was done or planned
Locations
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Contact Information
Primary
Won Park
wonro.park@samsung.com
+82-2-3410-2612
Backup
Won Kyung Cho
wklove.cho@samsung.com
Time Frame
Start Date: 2022-11-01
Estimated Completion Date: 2031-12-31
Participants
Target number of participants: 92
Treatments
Experimental: POHIM_EM
adjuvant hypofractionated IMRT for endometrial cancer
Related Therapeutic Areas
Sponsors
Leads: Samsung Medical Center